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Introduction
Salicylic acid is a mono-hydroxyl benzoic acid, and naturally 
occurring in the bark of willow tree (Salix alba) [1]. It is an important 
active metabolite of aspirin, which acts as a prodrug to salicylic acid. 
The salts and esters of salicylic acid are known as salicylates that are 
widely used as rubefacient and analgesic in several topical formulations. 
Salicylic acid alleviates peeling of intercellular cement and binds with 
scales in the stratum corneum, thereby loosening the keratin. This 
keratolytic effect also renders an antifungal effect as removal of the 
stratum corneum suppresses the fungal growth [1,2]. It exerts anti-
inflammatory activity by suppressing the cyclooxygenase (COX) 
activity that caused to inhibition of pro-inflammatory mediators 
production. Therefore, it is widely used for the treatment of several skin 
diseases like acne, psoriasis, seborrhoeic dermatitis, calluses, keratosis 
pilaris, and warts due to its keratolytic, fungicidal, bacteriostatic, and 
photo-protective properties [3,4]. Salicylic acid is also a phytohormone 
and useful in growth and development of whole plant [5]. 
Sparfloxacin is a difluorinated quinolone antibiotic with broad 
spectrum antibacterial activity. Additionally, it also possesses a 
good in vitro activity against several unusual pathogens such as 
legionellae, chlamydia, rickettsiae, mycoplasmas, mycobacteria, etc. 
[6,7]. Sparfloxacin showed good topical absorption and had excellent 
penetration into upper and lower respiratory tissues; therefore it is 
extensively used in respiratory infections. It inhibits DNA replication 
and transcription in bacteria by inhibiting the DNA gyrase or 
topoisomerase IV enzyme [8]. The gastrointestinal discomfort and 
CNS effects are the most common adverse effects associated with 
sparfloxacin [9]. Chemical stability of pharmaceutical drugs or active 
ingredients is a matter of great concern as it affects the safety, efficacy, 
and shelf life of drugs or drug products [10]. Therefore, it is important 
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to find out an alternate approach, which could enhance the stability of 
drugs by changing the structural (bond strength, bond length, dipole 
moment etc.) properties of these compounds. 
Recently, biofield treatment has been reported to alter the physical 
and structural properties of various living and non-living things [11,12]. 
Biofield is the electromagnetic field that permeates and surrounds the 
living organisms. It is the scientific term, used for biologically created 
electromagnetic energy, essential for regulation and communications 
within the organism [13]. As per Planck M, electrical current exists 
inside the human body in the form of vibratory energy particles 
like ions, protons, and electrons. These moving particles generates a 
magnetic field in the human body [14,15].  Mr. Trivedi has the ability to 
harness the energy from environment or universe and can transmit into 
any living or nonliving object around this Globe. The object(s) always 
receive the energy and responding into useful way, this process is 
known as biofield treatment. The National Center for Complementary 
and Alternative Medicine considered this biofield treatment (therapy) 
in subcategory of energy therapies [16]. 
Mr. Trivedi’s biofield treatment has substantially changed the 
antimicrobial susceptibility, biochemical reactions pattern and 
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biotype number of different human pathogens [13,17]. It also showed 
a significant impact in the field of agriculture and biotechnology, 
with respect to yield, nutrient value, and quality of products [18-
20]. Mr. Trivedi’s biofield treatment has also changed the various 
physicochemical and structural properties of metals and ceramics 
[12,21-23]. 
By conceiving the impact of biofield treatment on structural 
property of metals and ceramics, the present study was aimed to 
further explore the biofield treatment on two pharmaceutical drugs i.e., 
salicylic acid and sparfloxacin with respect to effects on their structural 
property. The effects were analyzed using Fourier transform infrared 
(FT-IR) and Ultraviolet-Visible (UV-Vis) spectroscopic techniques.  
Materials and Methods
Study design
Salicylic acid was procured from Qualigens Fine Chemicals 
(Mumbai, India), and sparfloxacin was procured from Sigma-Aldrich 
(MA, USA). Each drug sample was divided into two parts i.e., control 
and treatment. The control groups were remained as untreated and 
treatment groups were handed over in sealed pack to Mr. Trivedi for 
biofield treatment under standard laboratory condition. Mr. Trivedi 
provided this treatment through his energy transmission process to the 
treatment groups without touching the samples. After that, both the 
control and treated samples of salicylic acid and sparfloxacin (Figure 
1) were analyzed using FT-IR spectroscopy and UV-vis spectroscopy.  
FT-IR spectroscopic characterization
FT-IR spectra of salicylic acid and sparfloxacin (control and 
treated) were recorded on Shimadzu’s Fourier transform infrared 
spectrometer (Japan) with the frequency range of 4000-500 cm-1. The 
FT-IR spectroscopic analysis was carried out to evaluate the impact of 
biofield treatment at atomic level like bond strength, and stability of the 
structure of both drugs [24]. 
UV-Vis spectroscopic analysis
UV spectroscopic analysis of salicylic acid and sparfloxacin were 
acquired on a Shimadzu UV-2400 PC series spectrophotometer 
with 1 cm quartz cell and a slit width of 2.0 nm. The analysis was 
performed using wavelength range of 200-400 nm. This study 
was performed to evaluate the effect of biofield treatment on the 
structural property of tested drugs with respect to functional groups 
and their position. 
Results and Discussion
FT-IR spectroscopic analysis
The FT-IR spectra of salicylic acid (control and treated) are shown 
in Figure 2. FT-IR spectrum of control sample (Figure 2a) showed 
characteristic vibrational peaks at wavenumber 3233 cm-1 and 2999-
2831 cm-1 that were assigned to OH and C-H stretching, respectively. 
The C=O (COO-) asymmetric and symmetric stretching were assigned 
to IR peaks observed at 1652-1670 cm-1 and 1386 cm-1, respectively. 
Further, IR peaks appeared at 1558-1610 cm-1 were attributed to C=C 
(phenolic) multiple peaks. The C-C stretching peaks were observed 
at 1444-1503 cm-1. The O-H (phenolic) bending was assigned to IR 
peak appeared at 1324 cm-1. The COO- (C-O) stretching and C-OH 
(phenolic) stretching were assigned to IR peaks appeared at 1296 cm-1 
and 1156-1248 cm-1, respectively. The vibrational peaks appeared at 
759-669 cm-1 were attributed to =C-H bending. The observed FT-IR data 
of control salicylic acid was well supported by the literature data [25].
The FT-IR spectrum of biofield treated salicylic acid (Figure 2b) 
showed the IR absorption peaks at 3233 and 2837-3004 cm-1 that were 
assigned to O-H and C-H stretching, respectively. Vibration peaks 
observed at 1662-1683 cm-1 and 1558-1612 cm-1 were attributed to 
C=O asymmetric stretching and C=C (phenolic) stretching peaks, 
respectively. In addition, C-C stretching peak was appeared at 1445-
1501 cm-1 and C=O (COO-) symmetric stretching peak was observed 
at 1387 cm-1. The O-H (Ph-OH) and =C-H bending peaks were 
appeared at 1324 cm-1 and 760-669 cm-1, respectively. Vibrational peaks 
observed at 1296 cm-1 and 1157-1249 cm-1 were assigned to COO- (C-O) 
stretching and phenolic (C-OH) stretching, respectively. 
Overall, the FT-IR data indicates a significant impact of biofield 
treatment at atomic level of salicylic acid as compared to control. The 
FT-IR data of treated salicylic acid exhibited the shifting in wavenumber 
of some bonds with respect to control sample. For instance, an upstream 
shifting in wavenumber of C-H stretching from 2999 (control) to 3004 
cm-1 (treated) and 2831 to 2837 cm-1; and C=O asymmetric stretching 
vibrations from 1670 to 1683 cm-1 and 1652 to 1662 cm-1. The frequency 
of vibrational peak (ν) depends on two factors i.e., force constant and 
reduced mass, which can be explained by following equation [26].
ν=1/2πc √(k/μ)
here, c is speed of light, k is force constant and μ is reduced mass.    
If reduced mass is constant, then the frequency is directly 
proportional to the force constant; therefore, increase in frequency 
of any bond suggested a possible enhancement in force constant 
of respective bond [24]. Based on this it is speculated that the force 
constant and bond strength of C-H and C=O bond might increased 
after biofield treatment as compared to control. Additionally, the 
intensity of peaks at 1558 cm-1 (aromatic C=C stretching) and 1501 
cm-1 (C-C stretching) was significantly increased in biofield treated 
sample, as compared to control. This might be due to alteration in ratio 
of change in dipole moment (∂µ) to change in bond distance (∂r) [27].
The FT-IR spectrum of control sparfloxacin is shown in (Figure 
3a), which showed the characteristic vibrational peaks at 3093-3462 
cm-1 that were collectively assigned to O-H and N-H stretching. 
Vibrational peaks appeared at 2848-2961 cm-1 were assigned to C-H 
(CH3) stretching. Further, the vibrational peaks observed at 1715 cm-1 
and 1641 cm-1 were attributed to C=O (COO-) asymmetric stretching 
and C=O (pyridone) stretching, respectively. The IR peaks appeared at 
1586, and 1533 cm-1 were assigned to C=C (benzene ring) stretching 
and N-H bending, respectively. The C-H asymmetrical bending and 
C=O (COO-) symmetric stretching peaks were observed at 1437 and 
1334 cm-1 respectively. The C-N (aryl) stretching and C-F stretching 
peaks were assigned to IR peaks observed at 1186-1293 cm-1 and 
1151 cm-1, respectively. Further, the IR peaks appeared at 1084, 1029, 
and 668 cm-1 were assigned to C-O (COO-) stretching, C-N (alkyl) 
stretching, and =C-H bending, respectively. The FT-IR data of control 
sparfloxacin was well supported by the literature data [28,29]. 
  
Figure 1: Chemical structure of (a) salicylic acid and (b) sparfloxacin.
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The FT-IR spectrum (Figure 3b) of treated sparfloxacin showed 
the characteristic vibrational peaks at 3084-3462 cm-1, were attributed 
to overlapped peaks of O-H and N-H stretching. The vibrational peak 
appeared at 2818-2955 cm-1 were assigned to C-H (CH3) stretching. 
Further, the vibrational peaks appeared at 1715 cm-1 and 1648 cm-1 were 
attributed to C=O (COO-) asymmetric stretching and C=O (pyridone) 
stretching, respectively. The IR peaks observed at 1628, 1586, and 1533-
1507 cm-1 were attributed to C=C (pyridone) stretching, C=C (benzene 
ring) stretching, and N-H bending, respectively. The IR peaks observed at 
1437 and 1335 cm-1 were attributed to asymmetrical bending of C-H group 
and symmetric stretching of C=O (COO-) group, respectively. Likewise, the 
C-N (aryl) stretching and C-F stretching were assigned to peaks observed 
at 1289-1186 cm-1 and 1135 cm-1, respectively. Further, the C-O (COO-
) stretching, C-N (alkyl) stretching, and =C-H bending were assigned to 
absorption peak observed at 1084, 1030, and 652 cm-1, respectively. 
Overall, the FT-IR results of biofield treated sparfloxacin exhibited 
the shifting in wavenumber of some bonds with respect to control 
sample. For instance, a downstream shifting in frequency  of vibrational 
peaks like C-H stretching from 2961 to 2955 cm-1 and 2848 to 2818 
cm-1; C-F stretching from 1151 to 1135 cm-1; and upstream shifting in 
wavenumber of C=O (pyridone) stretching from 1641 to 1648 cm-1. 
This slight change in wavenumber of peaks referred to corresponding 
changes in the force constant of that bond as compared to control. 
Increase in the force constant of stretching peaks, suggests the 
enhancement of bond strength and vice versa; likely, increasing in the 
force constant of bending peaks referred to increase in rigidity of bond 
in a molecule [25]. Additionally, C=C stretching (pyridone) peaks at 
1628 cm-1 and N-H bending 1507 cm-1 were not observed in the control 
sample of sparfloxacin. However, these were significantly observed in 
treated sample. This might be observed due to very low intensity to be 
 
Figure 2: FT-IR spectra of salicylic acid (a) control and (b) treated.
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Figure 3: FT-IR spectra of sparfloxacin (a) control and (b) treated.
detected in control sample. It indicates a possible change in the ∂µ/∂r 
of these peaks [27], which might be occurred due to impact of biofield 
treatment at the atomic level (dipole moment) of treated sparfloxacin 
as compared to control.
UV-Vis spectroscopy 
UV spectra of control and treated samples of salicylic acid are 
shown in Figure 4. It revealed that UV absorption peaks of treated 
sample were shifted to higher wavelength (λmax) from 295.8 → 302.4 
nm and 231.2 → 234.4 nm. The existing literature on principle of UV 
spectroscopy suggests that a compound can absorbs UV light due to 
presence of either or both conjugated pi (π) -bonding systems (π - π* 
transition) and nonbonding electron system (n-π* transition) in the 
compound. The UV absorption phenomenon occurred when electrons 
travelled from low energy orbital (i.e., σ, n and π) to high energy orbital 
(i.e., σ* and π*). There is certain energy gape between σ-σ*, σ-π*, π -π* 
and n-π* orbitals. When this energy gap altered, the wavelength (λmax) 
was also altered respectively [24]. Based on this, it is speculated that, 
due to influence of biofield treatment, the energy gap between  π - π* 
and n -  π* transition in salicylic acid might be altered, which causes 
shifting of wavelength (λmax) in treated salicylic acid as compared to 
control.
UV spectra of sparfloxacin (control and treated) are shown in 
Figure 5. It showed the shifting of lambda max (λmax) of UV absorption 
peaks in treated sample from 373.8 → 380.6 nm and 224.2 → 209.2 nm; 
and absorption peak at 304.4 were appeared at the same wavelength 
in both samples. This suggests a possible alteration in the energy gap 
between π-π* and n-π* transition in treated sparfloxacin as compared 
to control. 
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Figure 4: UV spectra of salicylic acid (a) control and (b) treated.
Figure 5: UV spectra of sparfloxacin (a) control and (b) treated.
Conclusion
The FT-IR data of both drugs showed an alteration in the 
wavenumber of some functional groups like C-H and C=O (COO-) 
in treated salicylic acid, and C-H, C=O (pyridine), and C-F in treated 
sparfloxacin as compared to their respective control. The increased 
intensity of peaks at 1558 and 1501 cm-1 was found in treated salicylic 
acid. While the increased intensity of peaks at 1628 and 1507 cm-1 
was found in treated sparfloxacin, as compared to respective control. 
The UV spectra of both drugs showed a biofield induce shifting of 
wavelength (λmax) as compared to control. This might be occurred due 
to some possible alteration in structural properties like force constant, 
bond strength, dipole moments etc. of treated drugs through the 
biofield treatment. Due to possible alterations in structural properties 
of treated drugs, the chemical stability might also be altered, which 
could be beneficial for the shelf life of pharmaceutical drugs. 
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